50924-49-7 Mizoribine AKSci Q571
 
 
Loading Please Wait...
  Q571    
Mizoribine
, 98% (HPLC)
 
4-Carbamoyl-1-b-D-ribofuranosylimidazolium-5-olate




IDENTITY
CAS Number:50924-49-7
MDL Number:MFCD00057221
MF:C9H13N3O6
MW:259.22
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:219-225°C
Optical Rotation:-27° to -25° (c=2,H2O)
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:DMSO
Application(s):Imidazole nucleoside and an immunosuppressive agent
Form:Free base
Research Area:Immunology

REVIEW

 Mizoribine (trade name Bredinin) is a natural product, first isolated from the mould Eupenicillium brefeldianum, in Japan in 1971. Mizoribine, an imidazole nucleoside is an immunosuppressive drug that has been used in kidney transplantation, which is the optimal form of therapy for children and adolescents with end-stage kidney disease. The compound has also been used to treat steroid-resistant nephrotic syndrome, IgA nephropathy, lupus, as well as for adults with rheumatoid arthritis, lupus nephritis and other rheumatic diseases. MZB mode of action is via selective inhibition of inosine monophosphate synthetase and guanosine monophosphate synthetase, resulting in the complete inhibition of guanine nucleotide synthesis without incorporation into nucleotides. It arrests DNA synthesis in the S phase of cellular division.

REFERENCES
[1]Ishikawa H. Mizoribine and mycophenolate mofetil. Curr Med Chem. 1999 Jul;6(7):575.
[2] Yokota S. Mizoribine: mode of action and effects in clinical use. Pediatr Int. 2002 Apr;44(2):196-8.
[3] Takei S. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Pediatr Int. 2002 Apr;44(2):205-9.
[4] Tsuzuki K. Role of mizoribine in renal transplantation. Pediatr Int. 2002 Apr;44(2):224-31.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H315; H319; H335; H314; H318; H315; H319; H335; H302; H402; H302; H315; H319;

Precautionary Statements
P201; P202; P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P308+P313; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


Current as of April 24, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives >


PubChem
  @PubMed